Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
Open Access
- 1 January 2008
- journal article
- Published by Elsevier BV in Journal of Cardiovascular Magnetic Resonance
- Vol. 10 (1), 5
- https://doi.org/10.1186/1532-429x-10-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and managementExpert Opinion on Pharmacotherapy, 2007
- Noninvasive Imaging in MyocarditisJournal of the American College of Cardiology, 2006
- Herceptin and the Heart — A Molecular Modifier of Cardiac FailureNew England Journal of Medicine, 2006
- Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31Journal of Clinical Oncology, 2005
- Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Delayed Contrast-Enhanced Magnetic Resonance Imaging For the Detection of Autoimmune Myocarditis and Long-term Follow-UpJournal of Cardiovascular Magnetic Resonance, 2005
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- Assessing the Risk of Breast CancerNew England Journal of Medicine, 2000
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987